trial · primary record
Radiotherapy
Prostatic Neoplasms
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 691 |
| Primary completion | 2031-09-15 |
| Primary endpoint | Prostate specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) Metastatic Progression-free Survival (ppMPFS) |
| Registry ID | NCT04557059 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:10.215Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04557059
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.